Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01817634
Other study ID # 2012/334
Secondary ID
Status Completed
Phase N/A
First received March 20, 2013
Last updated May 3, 2017
Start date November 2013
Est. completion date September 2016

Study information

Verified date May 2017
Source University Ghent
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

New approaches are needed to prevent growth failure in children from low- and middle-income countries (LMIC). To date, nutrition intervention studies have focused on micronutrient and energy content of complementary foods and have yielded only small to moderate effects on growth and development. There appears to be a missing link that mediates and reduces the expected beneficial effect. Child populations in LMIC show an asymptomatic environmental enteropathy that is characterized by a reduced size of the small intestinal villi, decreased gut integrity and a chronic inflammatory response in the gut. Results from studies in industrialized countries suggest that ω3 long-chain polyunsaturated fatty acids (ω3 LCPUFAs) improve immune response and gut integrity. These reported beneficial effects could result in even more important physiological implications for children from LMIC and will ultimately contribute to their healthy growth and development.

The hypothesis of the OME³Jim study is that an increased intake of ω3 LCPUFAs through complementary foods and human milk has an effect on infant growth and development in a context of high malnutrition rates and low ω3 LCPUFAs intake. This study will identify whether intake by either or both mother and infant is more effective.

The specific objectives of the OME³Jim study are:

1. To test the effect of supplementing infants with an ω3 LCPUFAs fortified food supplement on infant growth, morbidity, nutritional status and development;

2. To test the effect of supplementing lactating mothers with an ω3 LCPUFAs oil capsule on infant growth, nutritional status and development;

3. To test the combined effect (dose response) of supplementing ω3 LCPUFAs to lactating mothers and infant on infant growth, morbidity, nutritional status and development:

4. To test the effect of ω3 LCPUFAs supplementation on ω3 LCPUFA status in infants and human milk.


Recruitment information / eligibility

Status Completed
Enrollment 720
Est. completion date September 2016
Est. primary completion date September 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Months to 12 Months
Eligibility Inclusion Criteria:

- Singleton infants

- 6-12 months old

- Not suffering from acute malnutrition (wasting): WHZ > -2 , no edema

- Infants currently being breastfed

- Anticipated local residence for the study duration

- Not planning to leave the study area for more than 1 month

Exclusion Criteria:

- Current supplement use or medical treatment of infant and/or mother

- Infants developing severe anemia (<70 g/L) or edema are referred to the nearby health institution for evaluation and treatment, and are omitted from the trial

- Presence of congenital abnormalities

Study Design


Intervention

Dietary Supplement:
Fish powder corn-soy blend'+ Fish oil capsule.
Omega 3 food supplement: 500 mg DHA + EPA, daily for 12 months. Omega 3 capsule: 500 mg DHA + EPA, daily for 12 months.
Fish powder corn-soy blend + corn oil capsule.
Omega 3 food supplement: 500 mg DHA + EPA, daily for 12 months. Control capsule: 0 mg DHA + EPA, daily for 12 months.
Corn-soy blend + fish oil capsule.
control food supplement: 0 mg DHA + EPA, daily for 12 months. Omega 3 capsule: 500 mg DHA + EPA, daily for 12 months.
Corn-soy blend + corn oil capsule.
control food supplement: 0 mg DHA + EPA, daily for 12 months. Control capsule: 0 mg DHA + EPA, daily for 12 months.

Locations

Country Name City State
Ethiopia Jimma University Jimma

Sponsors (5)

Lead Sponsor Collaborator
University Ghent Jimma University, Nutricia Research Fundation, Nutrition Tiers Monde, VLIR Institutional University Collaboration Programme

Country where clinical trial is conducted

Ethiopia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in length-for-age Z-score over time up to 12 months. Length-for-age Z-score using the WHO 2006 growth reference chart. Every month since baseline until 12 months.
Primary Development score after study inclusion until 12 months after inclusion. Development score: Denver II test and Ages-Stages Social-Emotional Questionnaire. 6-monthly since baseline up to 12 months.
Secondary Weight-for-length Z-score up to 12 months. Weight-for-length Z-score: WHO 2006 growth reference chart. 6-monthly up to 12 months.
Secondary Head circumference up to 12 months after inclusion Head circumference measurement. Monthly up to 12 months after inclusion
Secondary Mid-upper arm circumference up to 12 months after inclusion. Mid-upper arm circumference. Monthly until 12 months after inclusion.
Secondary Prevalence of stunting (HAZ <-2- up to 12 months after inclusion. According to WHO 2006 growth reference chart. 6-monthly until 12 months after inclusion.
Secondary Prevalence of wasting (WHZ <-2) until 12 months after inclusion. According to WHO 2006 growth reference chart. 6-monthly until 12 months after inclusion
Secondary C-reactive protein concentration until 12 months after inclusion C-reactive protein concentration. 6-monthly until 12 months after inclusion
Secondary Haemoglobin concentration until 12 months Haemoglobin concentration in blood sample. 6-monthly until 12 months after inclusion
Secondary Infant morbidity at weekly intervals. Infant morbidity (acute respiratory infection, diarrhoea, fever, malaria): weekly recall by caregiver, malaria by microscopy. weekly until 12 months after inclusion
Secondary Breast milk concentrations of DHA/EPA/AA until 12 months after inclusion Breast milk collections to determine milk levels of DHA/EPA/AA. 6-monthly until 12 months after inclusion
Secondary Infant blood concentrations of DHA/EPA/AA until 12 months after inclusion. Blood sample for measuring infant blood levers of DHA/EPA/AA. 6-monthly until 12 months after inclusion
See also
  Status Clinical Trial Phase
Terminated NCT05543759 - Simplified Treatment Protocol for Acute Malnutrition in Venezuela
Recruiting NCT04488718 - ESj- Powder Complete T&A Study N/A
Completed NCT02858011 - The Effect of a Cash Transfer Program and Preventive Nutrition Packages on Household Welfare and Child Nutritional Status in Mali Phase 4
Recruiting NCT05473312 - Women Supporting Women to Improve Infant and Child Feeding Practices N/A
Completed NCT04067284 - Homemade Yogurt Supplementation to Prevent Stunting N/A
Completed NCT02988180 - Intervention on Development and Growth at Children in Poverty N/A
Completed NCT03886467 - Strategies to Increase Milk Consumption by Young Nepali Children N/A
Terminated NCT04133766 - Community-based Nutrition Program Effectiveness Evaluation in Afghanistan N/A
Active, not recruiting NCT04257383 - The Sugira Muryango PLAY Collaborative N/A
Recruiting NCT05889520 - The UFIM (Ultraprocessed Foods In Breast Milk) Project
Completed NCT02427945 - Leveraging an Existing Large-scale Safe Water Program to Deliver Nutrition Messages at a Low Marginal Cost N/A
Recruiting NCT05181293 - Mobile Gaming App to Improve Child Nutrition in Nigeria N/A
Completed NCT02071563 - Effectiveness and Cost-Effectiveness of Four Formulations of Food Supplements for the Prevention of Wasting and Stunting in Burkina Faso N/A
Completed NCT01497236 - Effectiveness of Nutritional Supplementation in Preventing Malnutrition in Children With Infection in Karamoja, Uganda N/A
Completed NCT02914002 - Psychoeducational Intervention Model to Improve Nutritional Status in Low Resource Settings N/A
Completed NCT02257437 - Acceptability of a Multiple Micronutrient-Fortified Lipid-Based Nutrient Supplement for Children Under Two in Cambodia N/A
Completed NCT02258802 - Pilot Psychoeducational Intervention Model to Improve Nutritional Status in Low Resource Settings N/A
Completed NCT03751475 - Optimizing Acute Malnutrition Management in Children Aged 6 to 59 Months in Democratic Republic of Congo N/A
Completed NCT01873196 - Food Aid Quality Review: Feasibility and Acceptability Study of Corn Soy Blend and Fortified Vegetable Oil in Malawi N/A
Recruiting NCT05774314 - The Impact of Community Health Workers on Child Malnutrition in the Philippines N/A